Hiroyasu Kaneda
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Clinical impact of opioid use in patients with urothelial carcinoma treated with pembrolizumab: a single center retrospective study.
Journal: Immunotherapy
Published: July 15, 2026
Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.
Journal: International journal of clinical oncology
Published: April 21, 2026
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 11, 2026
Anti-programmed Death-ligand 1 Antibody-associated Eosinophilic Granulomatosis with Polyangiitis in Non-small Cell Lung Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: December 24, 2025
Onset and Outcomes of Immune-related Adverse Events in Genitourinary Cancer Treated With Immune Checkpoint Inhibitors.
Journal: In vivo (Athens, Greece)
Published: December 08, 2025
A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common EGFR mutation-positive NSCLC.
Journal: Therapeutic advances in medical oncology
Published: November 24, 2025
A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA).
Journal: Journal of cachexia, sarcopenia and muscle
Published: November 20, 2025
Quantitative evaluation of healthcare information provided to patients with thoracic malignancies: patient satisfaction survey of the Japan Lung Cancer Society.
Journal: International journal of clinical oncology
Published: October 05, 2025
Immune checkpoint inhibitor resistance in non-small cell lung cancer: limits of vascular endothelial growth factor inhibition and new directions.
Journal: Journal of thoracic disease
Published: September 12, 2025
Management of Advanced Lung Cancer in Pregnancy: Multidisciplinary Treatment and Early Delivery.
Journal: Internal medicine (Tokyo, Japan)
Published: June 04, 2025
Immune checkpoint inhibitor-induced interstitial lung disease with and without CTLA-4 regimen in non-small cell lung cancer patients and PD-L1 < 1 %: A multicenter, retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 26, 2025
Last Updated: 09/26/2026